Target intelligence / Profile preview

Retinoic acid receptor responder 2 pseudogene 7 (RARRES2P7)

Target
RARRES2P7
Molecular classification
Other (pseudogene)
01

Overview

Retinoic acid receptor responder 2 pseudogene 7 (RARRES2P7) is classified as a processed pseudogene—a genomic DNA sequence that is similar to a functional gene (in this case, likely RARRES2/Chemerin), but contains mutations or lacks necessary elements for normal expression, precluding it from encoding a functional protein. Pseudogenes like RARRES2P7 are typically regarded as non-functional, though some pseudogenes have been shown to be transcribed and, in certain contexts, could have regulatory RNA functions, but no such evidence is established for RARRES2P7 specifically. As such, RARRES2P7 is not considered a biological or therapeutic target. Key point: RARRES2P7 is a non-coding pseudogene, not a functional receptor, enzyme, or protein, and should not be considered a drug target.

Other names
retinoic acid receptor responder (tazarotene induced) 2 pseudogene 7
02

Biological functions

Most pseudogenes do not have a direct biological function, but some may regulate expression of related protein-coding genes via RNA interference or other non-coding RNA mechanisms
03

Disease associations

No established disease roles for RARRES2P7 itself. Pseudogenes in general may occasionally act as regulators or be involved in disease through RNA-based mechanisms, but no specific evidence for RARRES2P7

Beyond the preview

Go deeper on Retinoic acid receptor responder 2 pseudogene 7 (RARRES2P7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinoic acid receptor responder 2 pseudogene 7 (RARRES2P7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call